140 related articles for article (PubMed ID: 9890948)
1. PDR16 and PDR17, two homologous genes of Saccharomyces cerevisiae, affect lipid biosynthesis and resistance to multiple drugs.
van den Hazel HB; Pichler H; do Valle Matta MA; Leitner E; Goffeau A; Daum G
J Biol Chem; 1999 Jan; 274(4):1934-41. PubMed ID: 9890948
[TBL] [Abstract][Full Text] [Related]
2. The yeast Saccharomyces cerevisiae Pdr16p restricts changes in ergosterol biosynthesis caused by the presence of azole antifungals.
Šimová Z; Poloncová K; Tahotná D; Holič R; Hapala I; Smith AR; White TC; Griač P
Yeast; 2013 Jun; 30(6):229-41. PubMed ID: 23606207
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of PDR16 confers resistance to complex sphingolipid biosynthesis inhibitor aureobasidin A in yeast Saccharomyces cerevisiae.
Katsuki Y; Yamaguchi Y; Tani M
FEMS Microbiol Lett; 2018 Feb; 365(3):. PubMed ID: 29240942
[TBL] [Abstract][Full Text] [Related]
4. PDR16-mediated azole resistance in Candida albicans.
Saidane S; Weber S; De Deken X; St-Germain G; Raymond M
Mol Microbiol; 2006 Jun; 60(6):1546-62. PubMed ID: 16796687
[TBL] [Abstract][Full Text] [Related]
5. Yeast Sec14-like lipid transfer proteins Pdr16 and Pdr17 bind and transfer the ergosterol precursor lanosterol in addition to phosphatidylinositol.
Šťastný D; Petrisková L; Tahotná D; Bauer J; Pokorná L; Holič R; Valachovič M; Pevala V; Cockcroft S; Griač P
FEBS Lett; 2023 Feb; 597(4):504-514. PubMed ID: 36482167
[TBL] [Abstract][Full Text] [Related]
6. Yeast phosphatidylinositol transfer protein Pdr17 does not require high affinity phosphatidylinositol binding for its cellular function.
Pevalová Z; Pevala V; Blunsom NJ; Tahotná D; Kotrasová V; Holič R; Pokorná L; Bauer JA; Kutejová E; Cockcroft S; Griač P
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Oct; 1864(10):1412-1421. PubMed ID: 31302248
[TBL] [Abstract][Full Text] [Related]
7. Impaired biosynthesis of ergosterol confers resistance to complex sphingolipid biosynthesis inhibitor aureobasidin A in a PDR16-dependent manner.
Fukuda S; Kono Y; Ishibashi Y; Tabuchi M; Tani M
Sci Rep; 2023 Jul; 13(1):11179. PubMed ID: 37429938
[TBL] [Abstract][Full Text] [Related]
8. Deletion of the PDR16 gene influences the plasma membrane properties of the yeast Kluyveromyces lactis.
Toth Hervay N; Goffa E; Svrbicka A; Simova Z; Griac P; Jancikova I; Gaskova D; Morvova M; Sikurova L; Gbelska Y
Can J Microbiol; 2015 Apr; 61(4):273-9. PubMed ID: 25742422
[TBL] [Abstract][Full Text] [Related]
9. Drug susceptibilities of yeast cells are affected by membrane lipid composition.
Mukhopadhyay K; Kohli A; Prasad R
Antimicrob Agents Chemother; 2002 Dec; 46(12):3695-705. PubMed ID: 12435664
[TBL] [Abstract][Full Text] [Related]
10. Phosphatidylinositol binding of Saccharomyces cerevisiae Pdr16p represents an essential feature of this lipid transfer protein to provide protection against azole antifungals.
Holič R; Simová Z; Ashlin T; Pevala V; Poloncová K; Tahotná D; Kutejová E; Cockcroft S; Griač P
Biochim Biophys Acta; 2014 Oct; 1842(10):1483-90. PubMed ID: 25066473
[TBL] [Abstract][Full Text] [Related]
11. Novel target genes of the yeast regulator Pdr1p: a contribution of the TPO1 gene in resistance to quinidine and other drugs.
do Valle Matta MA; Jonniaux JL; Balzi E; Goffeau A; van den Hazel B
Gene; 2001 Jul; 272(1-2):111-9. PubMed ID: 11470516
[TBL] [Abstract][Full Text] [Related]
12. Role of Candida albicans transcription factor Upc2p in drug resistance and sterol metabolism.
Silver PM; Oliver BG; White TC
Eukaryot Cell; 2004 Dec; 3(6):1391-7. PubMed ID: 15590814
[TBL] [Abstract][Full Text] [Related]
13. Manipulation of major membrane lipid synthesis and its effects on sporulation in Saccharomyces cerevisiae.
Deng L; Nagasawa J; Ono Y; Ishikawa Y; Kakihara T; Fukuda R; Ohta A
Biosci Biotechnol Biochem; 2008 Sep; 72(9):2362-8. PubMed ID: 18776695
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of
Kalra S; Tanwar S; Bari VK
Microb Drug Resist; 2024 May; ():. PubMed ID: 38727600
[TBL] [Abstract][Full Text] [Related]
15. The yeast multidrug resistance pump, Pdr5p, confers reduced drug resistance in erg mutants of Saccharomyces cerevisiae.
Kaur R; Bachhawat AK
Microbiology (Reading); 1999 Apr; 145 ( Pt 4)():809-818. PubMed ID: 10220160
[TBL] [Abstract][Full Text] [Related]
16. Systematic analysis of yeast strains with possible defects in lipid metabolism.
Daum G; Tuller G; Nemec T; Hrastnik C; Balliano G; Cattel L; Milla P; Rocco F; Conzelmann A; Vionnet C; Kelly DE; Kelly S; Schweizer E; Schüller HJ; Hojad U; Greiner E; Finger K
Yeast; 1999 May; 15(7):601-14. PubMed ID: 10341423
[TBL] [Abstract][Full Text] [Related]
17. Functional dissection of Pdr1p, a regulator of multidrug resistance in Saccharomyces cerevisiae.
Kolaczkowska A; Kolaczkowski M; Delahodde A; Goffeau A
Mol Genet Genomics; 2002 Mar; 267(1):96-106. PubMed ID: 11919720
[TBL] [Abstract][Full Text] [Related]
18. A yeast strain lacking lipid particles bears a defect in ergosterol formation.
Sorger D; Athenstaedt K; Hrastnik C; Daum G
J Biol Chem; 2004 Jul; 279(30):31190-6. PubMed ID: 15155725
[TBL] [Abstract][Full Text] [Related]
19. AP1-mediated multidrug resistance in Saccharomyces cerevisiae requires FLR1 encoding a transporter of the major facilitator superfamily.
Alarco AM; Balan I; Talibi D; Mainville N; Raymond M
J Biol Chem; 1997 Aug; 272(31):19304-13. PubMed ID: 9235926
[TBL] [Abstract][Full Text] [Related]
20. Isolation of a putative Candida albicans transcriptional regulator involved in pleiotropic drug resistance by functional complementation of a pdr1 pdr3 mutation in Saccharomyces cerevisiae.
Talibi D; Raymond M
J Bacteriol; 1999 Jan; 181(1):231-40. PubMed ID: 9864335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
